Edesa Biotech, Inc. — Form D

Edesa Biotech, Inc. of MARKHAM, A6, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-14. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
Joan ChypyhaDirectorMarkham, A6
David LiuDirectorMarkham, A6
Sean MacDonaldDirectorMarkham, A6
Patrick MarshallDirectorMarkham, A6
Pardeep NijhawanDirectorMarkham, A6
Frank OakesDirectorMARKHAM, A6
Charles OlsonDirectorMarkham, A6
Carlo SistilliDirectorMarkham, A6
Michael BrooksExecutive OfficerMarkham, A6
Stephen LemieuxExecutive OfficerMARKHAM, A6
Pardeep NijhawanExecutive OfficerMarkham, A6
Jennifer ChaoDirectorOakville, A6
Patrick MarshallRelated PersonMarkham, A6
Sean MacDonaldRelated PersonMarkham, A6
Pardeep NijhawanRelated PersonMarkham, A6
Charles OlsonRelated PersonMarkham, A6
David LiuRelated PersonMarkham, A6
Joan ChypyhaRelated PersonMarkham, A6
Michael BrooksRelated PersonMarkham, A6
Carlo SistilliRelated PersonMarkham, A6
Kathi NiffeneggerExecutive OfficerMarkham, A6
Paul PayDirectorMarkham, A6
Lorin JohnsonDirectorRaleigh, NC
Mark A McPartlandExecutive OfficerSouth San Francisco, CA
David Louis HillDirectorPort Hueneme, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2026-06-26D$3.5M$3.5M
2022-04-05D
2016-07-21D$6.8M$6.8M
2013-10-03D/A$12.0M$12.0M
2013-09-03D$12.0M
2013-04-11D$1.6M$1.6M
2013-01-15D$505K$505K
2012-10-31D$1.0M$1.0M

More